Hong Kong IT Stock News

Shanghai Junshi Biosciences (SEHK:1877) remains unprofitable, with annual losses worsening by an average of 2.7% over the past five years, and net profit margins showing no signs of improvement. Despite this, analysts expect revenue to grow at a robust 23.7% per year, significantly outpacing the 8.6% growth forecast for the broader Hong Kong market. With the company expected to stay in the red for at least three more years, investors are weighing the attraction of high sales growth against...

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...

Amid the backdrop of global economic shifts, Asian markets have shown resilience, with notable gains in key indices such as Japan's Nikkei 225 and China's CSI 300. This environment has rekindled interest in penny stocks, a term that might seem outdated but remains relevant for investors seeking opportunities outside the mainstream. These stocks often represent smaller or newer companies that can offer unique growth potential when backed by robust financial health.

From what we can see, insiders were net buyers in Web3 Meta Limited's ( HKG:8093 ) during the past 12 months. That is...

With a price-to-earnings (or "P/E") ratio of 7.6x Cathay Pacific Airways Limited ( HKG:293 ) may be sending bullish...

Shanghai MicroPort MedBot (Group) Co., Ltd. ( HKG:2252 ), might not be a large cap stock, but it saw a significant...

If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...

Key Insights China CITIC Financial Asset Management's significant private companies ownership suggests that the key...

Key Insights The considerable ownership by retail investors in iDreamSky Technology Holdings indicates that they...

Key Insights Using the 2 Stage Free Cash Flow to Equity, Akeso fair value estimate is HK$201 Akeso's HK$116 share price...

Key Insights MicroPort Scientific's significant retail investors ownership suggests that the key decisions are...

For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...

Key Insights Using the 2 Stage Free Cash Flow to Equity, Sinopharm Group fair value estimate is HK$25.27 Sinopharm...

Yadea Group Holdings Ltd. ( HKG:1585 ), might not be a large cap stock, but it saw significant share price movement...

The board of CLP Holdings Limited ( HKG:2 ) has announced that it will pay a dividend of HK$0.63 per share on the 15th...

ANTA Sports Products Limited's ( HKG:2020 ) price-to-earnings (or "P/E") ratio of 15.1x might make it look like a sell...

Sun Hung Kai Properties Limited's ( HKG:16 ) investors are due to receive a payment of HK$2.80 per share on 20th of...

Key Insights Given the large stake in the stock by institutions, Biocytogen Pharmaceuticals (Beijing)'s stock price...

If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. In a perfect...

Tai Ping Carpets International Limited's ( HKG:146 ) solid earnings announcement recently didn't do much to the stock...

We can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com made...

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...

Lygend Resources & Technology's (HKG:2245) stock is up by a considerable 57% over the past three months. Since the...

Vietnam Manufacturing and Export Processing (Holdings) Limited ( HKG:422 ) shareholders that were waiting for something...